Overview

Trial of Ketamine and Lithium Therapy in Bipolar Depression

Status:
Withdrawn
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This study is looking at the safety and efficacy of combined ketamine and lithium therapy for treating patients with bipolar depression who are taking a mood stabilizer that is not working for them.
Phase:
Phase 2
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Ketamine
Lithium Carbonate